Cardiac involvement in Sandhoff's disease. Inborn error of glycosphingolipid metabolism

Leonard C. Blieden, Robert J. Desnick, John B. Carter, William Krivit, James H. Moller*, Harvey L. Sharp

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Abstract

Two siblings with Sandhoff's disease manifested clinical and laboratory evidence of significant cardiomyopathy. Postmortem examination of the hearts of both patients revealed anatomic, biochemical and ultrastructural abnormalities resulting from deficient activities of the enzymes hexosaminidase A and B. A study of the biochemical and ultrastructural changes in the hearts revealed the accumulation of the glycosphingolipid globoside in all cardiac tissues. The necropsy findings indicate that Sandhoff's disease should be considered in the differential diagnosis in infants with cardiomyopathy or mitral insufficiency.

Original languageEnglish
Pages (from-to)83-88
Number of pages6
JournalAmerican Journal of Cardiology
Volume34
Issue number1
DOIs
StatePublished - Jul 1974
Externally publishedYes

Funding

FundersFunder number
Beckman Liver Research Fund
Division of Research Resources71-778
Dwan Family Fund
National Foundation
Thomey Lipid Diseases Research Fund
National Institutes of HealthRR-400
American Heart AssociationCRBS 273, 259

    Fingerprint

    Dive into the research topics of 'Cardiac involvement in Sandhoff's disease. Inborn error of glycosphingolipid metabolism'. Together they form a unique fingerprint.

    Cite this